LIGAND PHARMACEUTICALS INC Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Ligand Pharmaceuticals Inc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Ligand Pharmaceuticals Inc Other Assets, Noncurrent for the quarter ending June 30, 2024 was $11.9M, a 165% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $11.9M +$7.43M +165% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $11.2M +$6.59M +142% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $6.39M +$4.66M +268% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $8.43M +$2.15M +34.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.5M -$1.82M -28.8% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $4.63M -$1.81M -28.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.74M +$485K +38.8% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $6.28M +$3.18M +103% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $6.32M +$3.49M +123% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $6.44M +$3.39M +111% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.25M -$3.02M -70.7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $3.1M -$10.6M -77.4% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.83M -$3.23M -53.3% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $3.05M +$1.78M +140% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $4.27M +$1.99M +87.7% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $13.7M +$11.2M +451% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $6.06M +$4.38M +261% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $1.27M -$5.13M -80.1% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $2.27M +$1.8M +383% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $2.49M +$1.99M +399% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.68M +$1.04M +162% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $6.4M +$5.5M +615% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $471K -$4.39M -90.3% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $499K -$1.53M -75.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $642K -$1.03M -61.5% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $894K -$927K -50.9% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $4.86M +$3.12M +179% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $2.03M +$284K +16.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.67M +$1.07M +177% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.82M +$1.75M +2501% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $1.74M +$1.72M +6359% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $1.74M +$1.5M +603% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 $603K +$302K +100% Jun 30, 2016 10-Q/A 2016-11-15
Q1 2016 $70K -$288K -80.4% Mar 31, 2016 10-Q/A 2016-11-15
Q4 2015 $27K -$180K -87% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $248K +$18K +7.83% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $301K +$48K +19% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $358K +$83K +30.2% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $207K -$92K -30.8% Dec 31, 2014 10-K/A 2016-11-15
Q3 2014 $230K -$114K -33.1% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $253K -$141K -35.8% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $275K -$176K -39% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $299K -$218K -42.2% Dec 31, 2013 10-K 2015-02-23
Q3 2013 $344K -$72K -17.3% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $394K -$130K -24.8% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $451K -$112K -19.9% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $517K -$221K -29.9% Dec 31, 2012 10-K/A 2014-12-12
Q3 2012 $416K -$361K -46.5% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $524K -$249K -32.2% Jun 30, 2012 10-Q/A 2012-11-14
Q1 2012 $563K Mar 31, 2012 10-Q/A 2012-11-14
Q4 2011 $738K -$100K -11.9% Dec 31, 2011 10-K 2013-03-14
Q3 2011 $777K Sep 30, 2011 10-Q/A 2012-02-10
Q2 2011 $773K Jun 30, 2011 10-Q/A 2012-02-10
Q4 2010 $838K Dec 31, 2010 10-K/A 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.